Indeks 
 Prethodno 
 Sljedeće 
 Cjeloviti tekst 
Postupak : 2018/2775(RSP)
Faze dokumenta na plenarnoj sjednici
Odabrani dokument : B8-0071/2019

Podneseni tekstovi :

B8-0071/2019

Rasprave :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Glasovanja :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Objašnjenja glasovanja

Doneseni tekstovi :

P8_TA(2019)0113

Rasprave
Srijeda, 13. veljače 2019. - Strasbourg Revidirano izdanje

16.11. Upotreba kanabisa u medicinske svrhe (B8-0071/2019) (glasovanje)
Videozapis govora
PV
 

- Prima della votazione sull'emendamento 11:

 
  
MPphoto
 

  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.

 
  
MPphoto
 

  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.

 
  
 

(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)

 
Posljednje ažuriranje: 24. svibnja 2019.Pravna obavijest - Politika zaštite privatnosti